Phaseline

Companies › HTIC

HTIC: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Respiratory; next expected readout Jan 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
HT31-1
humanized monoclonal antibody against citrullinated histone H3
HIST1H3APhase 1ARDS (Acute Respiratory Distress Syndrome)Jan 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07449572HT31-1Phase 1ARDS (Acute Respiratory Distress Syndrome)RespiratoryJan 2027

Targets

HIST1H3A (1)

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.